ロード中...
Letermovir for the prevention of cytomegalovirus infection and disease in transplant recipients: an evidence-based review
Cytomegalovirus (CMV) is a leading opportunistic infection in immune compromised patients, including allogeneic hematopoietic stem cell (HSCT) or solid organ transplant (SOT) recipients, where primary infection or reactivation is associated with increased morbidity and mortality. Antiviral drugs are...
保存先:
| 出版年: | Infect Drug Resist |
|---|---|
| 主要な著者: | , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Dove
2019
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6556539/ https://ncbi.nlm.nih.gov/pubmed/31239725 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/IDR.S180908 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|